4//SEC Filing
Bruno Anthony D 4
Accession 0001209191-20-018223
CIK 0001566044other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 5:55 PM ET
Size
7.5 KB
Accession
0001209191-20-018223
Insider Transaction Report
Form 4
Bruno Anthony D
Director
Transactions
- Award
Common Stock
2020-03-09+7,321→ 44,433 total - Award
Common Stock
2020-03-09+37,112→ 37,112 total
Footnotes (2)
- [F1]Received in or in connection with the merger of Foamix Pharmaceuticals Ltd. ("Foamix"), and Giants Merger Subsidiary Ltd., a direct, wholly owned subsidiary of Menlo Therapeutics Inc. ("Menlo"), in exchange for Foamix equity securities, as further described in the Form 4 filed by the Reporting Person on the date hereof in respect of the Reporting Person's interests in Foamix equity securities. The Reporting Person also received certain contingent stock rights which are subject to the terms and conditions of the contingent stock rights agreement, dated as of March 9, 2020, by and between American Stock Transfer & Trust Company, LLC and Menlo, or related contractual interests, either of which may entitle the Reporting Person to certain additional Menlo equity securities or the adjustment of certain Menlo equity securities, all as further described in that Current Report on Form 8-K filed by Menlo with the Securities and Exchange Commission on March 9, 2020.
- [F2]Represents restricted stock unit awards, each of which by its terms represents a contingent right to receive one share of common stock of Menlo.
Documents
Issuer
Menlo Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001374180
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 5:55 PM ET
- Size
- 7.5 KB